Arkolith/Insider Trading/YMAB/Form 4

WG Biotech ApS

Director, 10% OwnerY-mAbs Therapeutics, Inc. (YMAB) · full profile →Form 4 · filed Sep 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2025Tender(U)4.6M$8.60$39.2M0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753193-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML